Michael Y. Chang

1.3k total citations
22 papers, 992 citations indexed

About

Michael Y. Chang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Michael Y. Chang has authored 22 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in Michael Y. Chang's work include Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (5 papers) and Pleural and Pulmonary Diseases (4 papers). Michael Y. Chang is often cited by papers focused on Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (5 papers) and Pleural and Pulmonary Diseases (4 papers). Michael Y. Chang collaborates with scholars based in United States, United Kingdom and Israel. Michael Y. Chang's co-authors include David J. Sugarbaker, Michael T. Jaklitsch, Yolonda L. Colson, Steven J. Mentzer, Steven Μ. Albelda, William G. Richards, Steven Swanson, Lambros Zellos, Raphael Bueno and Siyamek Neragi-Miandoab and has published in prestigious journals such as ACS Applied Materials & Interfaces, Acta Biomaterialia and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Michael Y. Chang

22 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Y. Chang United States 18 452 212 207 163 145 22 992
Kim A. Selting United States 19 712 1.6× 184 0.9× 260 1.3× 39 0.2× 148 1.0× 53 1.3k
Monica L. Zepeda United States 15 318 0.7× 579 2.7× 442 2.1× 105 0.6× 198 1.4× 21 1.3k
Janean L. Fidel United States 19 520 1.2× 165 0.8× 195 0.9× 41 0.3× 151 1.0× 41 885
A.M.E. Claessen Netherlands 20 317 0.7× 342 1.6× 60 0.3× 141 0.9× 442 3.0× 38 1.4k
Pierre F. Neuenschwander United States 24 313 0.7× 328 1.5× 127 0.6× 134 0.8× 49 0.3× 46 1.7k
Soon Man Yoon South Korea 22 374 0.8× 193 0.9× 293 1.4× 363 2.2× 469 3.2× 85 1.4k
V. Gioia Italy 6 189 0.4× 207 1.0× 63 0.3× 223 1.4× 171 1.2× 8 858
Jade Jaffar Australia 21 430 1.0× 259 1.2× 29 0.1× 128 0.8× 166 1.1× 46 1.2k
Filippo Galli Italy 18 168 0.4× 179 0.8× 80 0.4× 159 1.0× 321 2.2× 57 1.2k
Roger H. Kobayashi United States 14 98 0.2× 161 0.8× 189 0.9× 209 1.3× 115 0.8× 28 744

Countries citing papers authored by Michael Y. Chang

Since Specialization
Citations

This map shows the geographic impact of Michael Y. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Y. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Y. Chang more than expected).

Fields of papers citing papers by Michael Y. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Y. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Y. Chang. The network helps show where Michael Y. Chang may publish in the future.

Co-authorship network of co-authors of Michael Y. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Y. Chang. A scholar is included among the top collaborators of Michael Y. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Y. Chang. Michael Y. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jae-Hyun, et al.. (2024). The impact of macro‐ and micro‐steatosis on the outcomes of patients who undergo liver transplant: Analysis of the UNOS‐STAR database. Liver International. 44(8). 2011–2037. 1 indexed citations
2.
Sun, Haotian, Michael Y. Chang, Kevin A. Carter, et al.. (2019). A multifunctional biodegradable brush polymer-drug conjugate for paclitaxel/gemcitabine co-delivery and tumor imaging. Nanoscale Advances. 1(7). 2761–2771. 17 indexed citations
3.
Liu, Chang, Depeng Wang, Qian Lu, et al.. (2018). Switchable Photoacoustic Imaging of Glutathione Using MnO2 Nanotubes for Cancer Diagnosis. ACS Applied Materials & Interfaces. 10(51). 44231–44239. 36 indexed citations
4.
Olofson, Andrea M., David Hernández Gonzalo, Michael Y. Chang, & Xiuli Liu. (2018). Steatohepatitic Variant of Hepatocellular Carcinoma: A Focused Review. Gastroenterology Research. 11(6). 391–396. 26 indexed citations
5.
Sun, Haotian, Michael Y. Chang, Qing Wang, et al.. (2017). Biodegradable zwitterionic sulfobetaine polymer and its conjugate with paclitaxel for sustained drug delivery. Acta Biomaterialia. 64. 290–300. 67 indexed citations
6.
Malik, Raza, Michael Y. Chang, Imad Nasser, et al.. (2009). The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. Journal of Gastroenterology and Hepatology. 24(4). 564–568. 70 indexed citations
7.
Linden, Philip A., Beow Y. Yeap, Michael Y. Chang, et al.. (2007). Morbidity of Lung Resection After Prior Lobectomy: Results from the Veterans Affairs National Surgical Quality Improvement Program. The Annals of Thoracic Surgery. 83(2). 425–432. 21 indexed citations
8.
Chang, Michael Y., Steven J. Mentzer, Yolonda L. Colson, et al.. (2007). Factors predicting poor survival after resection of stage IA non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 134(4). 850–856. 71 indexed citations
9.
Chang, Michael Y., et al.. (2005). Extrapleural pneumonectomy for malignant pleural mesothelioma. Multimedia Manual of Cardio-Thoracic Surgery. 2005(628). mmcts.2004.000133–mmcts.2004.000133. 6 indexed citations
10.
Sugarbaker, David J., Michael T. Jaklitsch, Raphael Bueno, et al.. (2004). Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. Journal of Thoracic and Cardiovascular Surgery. 128(1). 138–146. 268 indexed citations
11.
Chang, Michael Y. & David J. Sugarbaker. (2004). Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Thoracic surgery clinics/Thorac. surg. clin.. 14(4). 523–530. 29 indexed citations
12.
Chang, Michael Y. & David J. Sugarbaker. (2004). Innovative therapies: intraoperative intracavitary chemotherapy. Thoracic surgery clinics/Thorac. surg. clin.. 14(4). 549–556. 30 indexed citations
13.
Chang, Michael Y. & David J. Sugarbaker. (2003). Surgery for early stage non‐small cell lung cancer. Seminars in Surgical Oncology. 21(2). 74–84. 31 indexed citations
14.
Wiewrodt, Rainer, Kunjlata M. Amin, Michael Kiefer, et al.. (2003). Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Cancer Gene Therapy. 10(5). 353–364. 41 indexed citations
15.
Force, Seth, E.S. Lambright, William Siders, et al.. (2000). Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models.. PubMed. 60(11). 2955–63. 59 indexed citations
16.
Lanuti, Michael, Seth Force, Michael Y. Chang, et al.. (1999). Evaluation of an E1E4-Deleted Adenovirus Expressing the Herpes Simplex Thymidine Kinase Suicide Gene in Cancer Gene Therapy. Human Gene Therapy. 10(3). 463–475. 28 indexed citations
17.
Kouri, Claude El, Seth Force, Michael Y. Chang, et al.. (1999). Use of protamine to augment adenovirus-mediated cancer gene therapy. Gene Therapy. 6(9). 1600–1610. 41 indexed citations
18.
Rizk, Nabil P., Michael Y. Chang, Claude El Kouri, et al.. (1999). The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer. Cancer Gene Therapy. 6(4). 291–301. 26 indexed citations
19.
Kucharczuk, John C., B. Randazzo, Michael Y. Chang, et al.. (1997). Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma.. PubMed. 57(3). 466–71. 96 indexed citations
20.
Chang, Michael Y. & Jon B. Morris. (1997). Long‐Term Central Venous Access Through the Ovarian Vein. Journal of Parenteral and Enteral Nutrition. 21(4). 235–237. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim A. Selting Breakdown of academic impact, for papers by Monica L. Zepeda Breakdown of academic impact, for papers by Janean L. Fidel Breakdown of academic impact, for papers by A.M.E. Claessen Breakdown of academic impact, for papers by Pierre F. Neuenschwander Breakdown of academic impact, for papers by Soon Man Yoon Breakdown of academic impact, for papers by V. Gioia Breakdown of academic impact, for papers by Jade Jaffar Breakdown of academic impact, for papers by Filippo Galli Breakdown of academic impact, for papers by Roger H. Kobayashi
Rankless by CCL
2026